3-Hydroxyphencyclidine (3-HPC), a breakdown product of phencyclidine (PCP), is growing attracting clinical focus due to sparse information suggesting distinct biological actions. Preliminary studies demonstrate that 3-HPC may display separate responses on the central system, arguably contributing to some of the unexplained manifestations associated